Clinical Trial Update: Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy and tolerability of erenumab for trigeminal neuralgia is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• erenumab (erenumab)

Snippet

Sponsor: Danish Headache Center | Conditions: Trigeminal Neuralgia | Phase 2 | Status: UNKNOWN